Your browser doesn't support javascript.
loading
Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases.
DeBusk, Kendra; Ike, Chiemeka; Lindegger, Nicolas; Schwartz, Naomi; Surinach, Andy; Liu, Yutong; Forero-Torres, Andres.
Affiliation
  • DeBusk K; Seagen Inc., Bothell, WA.
  • Ike C; Seagen Inc., Bothell, WA.
  • Lindegger N; EMD Serono Inc.
  • Schwartz N; Seagen Inc., Bothell, WA.
  • Surinach A; Takeda Pharmaceuticals Inc.
  • Liu Y; Seagen Inc., Bothell, WA.
  • Forero-Torres A; Genesis Research, Hoboken, NJ.
J Manag Care Spec Pharm ; 28(6): 657-666, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35621719
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2022 Document type: Article Country of publication: Estados Unidos